{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:50:13Z","timestamp":1788544213486,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41401-023-01086-7","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:03:30Z","timestamp":1682417010000},"page":"1777-1789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-\u03baB activation by demethylating R149 of the p65 subunit"],"prefix":"10.1038","volume":"44","author":[{"given":"Zhen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-huai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-shuai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Valenzuela Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-dong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139\u2013e596.","journal-title":"Circulation."},{"key":"1086_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109:1580\u20139.","journal-title":"Circulation."},{"key":"1086_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3495","volume":"14","author":"M Maillet","year":"2013","unstructured":"Maillet M, van Berlo JH, Molkentin JD. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol. 2013;14:38\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1086_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","volume":"29","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008;29:1224\u201340.","journal-title":"Eur Heart J"},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12199-007-0007-8","volume":"13","author":"H Mano","year":"2008","unstructured":"Mano H. Epigenetic abnormalities in cardiac hypertrophy and heart failure. Environ Health Prev Med. 2008;13:25\u201329.","journal-title":"Environ Health Prev Med"},{"key":"1086_CR6","doi-asserted-by":"publisher","first-page":"887991","DOI":"10.3389\/fphar.2022.887991","volume":"13","author":"Z Lin","year":"2022","unstructured":"Lin Z, Li Z, Guo Z, Cao Y, Li J, Liu P, et al. Epigenetic reader bromodomain containing protein 2 facilitates pathological cardiac hypertrophy via regulating the expression of citrate cycle genes. Front Pharmacol. 2022;13:887991.","journal-title":"Front Pharmacol"},{"key":"1086_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jacbts.2019.05.011","volume":"4","author":"CF Liu","year":"2019","unstructured":"Liu CF, Tang WHW. Epigenetics in cardiac hypertrophy and heart failure. JACC Basic Transl Sci. 2019;4:976\u201393.","journal-title":"JACC Basic Transl Sci"},{"key":"1086_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41401-018-0044-4","volume":"40","author":"Q Li","year":"2019","unstructured":"Li Q, Li ZM, Sun SY, Wang LP, Wang PX, Guo Z, et al. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy. Acta Pharmacol Sin. 2019;40:589\u201398.","journal-title":"Acta Pharmacol Sin"},{"key":"1086_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.apsb.2020.12.012","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Guo Z, Lan R, Cai S, Lin Z, Li J, et al. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Acta Pharm Sin B. 2021;11:1286\u201399.","journal-title":"Acta Pharm Sin B."},{"key":"1086_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13:343\u201357.","journal-title":"Nat Rev Genet"},{"key":"1086_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/nature04048","volume":"436","author":"AJ Bannister","year":"2005","unstructured":"Bannister AJ, Kouzarides T. Reversing histone methylation. Nature. 2005;436:1103\u20136.","journal-title":"Nature."},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381\u201395.","journal-title":"Cell Res"},{"key":"1086_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1870-5","volume":"20","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20:245.","journal-title":"Genome Biol"},{"key":"1086_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molmed.2011.02.003","volume":"17","author":"CJ Peter","year":"2011","unstructured":"Peter CJ, Akbarian S. Balancing histone methylation activities in psychiatric disorders. Trends Mol Med. 2011;17:372\u20139.","journal-title":"Trends Mol Med"},{"key":"1086_CR15","doi-asserted-by":"publisher","first-page":"105104","DOI":"10.1016\/j.phrs.2020.105104","volume":"161","author":"S Cai","year":"2020","unstructured":"Cai S, Wang P, Xie T, Li Z, Li J, Lan R, et al. Histone H4R3 symmetric di-methylation by prmt5 protects against cardiac hypertrophy via regulation of Filip1L\/beta-catenin. Pharmacol Res. 2020;161:105104.","journal-title":"Pharmacol Res"},{"key":"1086_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07606-y","volume":"9","author":"JH Pyun","year":"2018","unstructured":"Pyun JH, Kim HJ, Jeong MH, Ahn BY, Vuong TA, Lee DI, et al. Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation. Nat Commun. 2018;9:5107.","journal-title":"Nat Commun"},{"key":"1086_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/epi.14.60","volume":"7","author":"QJ Zhang","year":"2015","unstructured":"Zhang QJ, Liu ZP. Histone methylations in heart development, congenital and adult heart diseases. Epigenomics. 2015;7:321\u201330.","journal-title":"Epigenomics"},{"key":"1086_CR18","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1172\/JCI46277","volume":"121","author":"QJ Zhang","year":"2011","unstructured":"Zhang QJ, Chen HZ, Wang L, Liu DP, Hill JA, Liu ZP. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest. 2011;121:2447\u201356.","journal-title":"J Clin Invest"},{"key":"1086_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2018.05.009","volume":"477","author":"Z Guo","year":"2018","unstructured":"Guo Z, Lu J, Li J, Wang P, Li Z, Zhong Y, et al. JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing beta-MHC expression. Mol Cell Endocrinol. 2018;477:1\u201314.","journal-title":"Mol Cell Endocrinol"},{"key":"1086_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1126\/science.1145801","volume":"318","author":"B Chang","year":"2007","unstructured":"Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science. 2007;318:444\u20137.","journal-title":"Science"},{"key":"1086_CR21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2013.10.056","volume":"155","author":"W Liu","year":"2013","unstructured":"Liu W, Ma Q, Wong K, Li W, Ohgi K, Zhang J, et al. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell. 2013;155:1581\u201395.","journal-title":"Cell."},{"key":"1086_CR22","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1074\/jbc.M112.433284","volume":"288","author":"M Unoki","year":"2013","unstructured":"Unoki M, Masuda A, Dohmae N, Arita K, Yoshimatsu M, Iwai Y, et al. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6). J Biol Chem. 2013;288:6053\u201362.","journal-title":"J Biol Chem"},{"key":"1086_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.1175865","volume":"325","author":"CJ Webby","year":"2009","unstructured":"Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science. 2009;325:90\u201393.","journal-title":"Science"},{"key":"1086_CR24","doi-asserted-by":"publisher","first-page":"e87982","DOI":"10.1371\/journal.pone.0087982","volume":"9","author":"C Poulard","year":"2014","unstructured":"Poulard C, Rambaud J, Hussein N, Corbo L, Le Romancer M. JMJD6 regulates ERalpha methylation on arginine. PLoS One. 2014;9:e87982.","journal-title":"PLoS One"},{"key":"1086_CR25","doi-asserted-by":"publisher","first-page":"22236","DOI":"10.1074\/jbc.M115.653543","volume":"290","author":"I Tikhanovich","year":"2015","unstructured":"Tikhanovich I, Kuravi S, Artigues A, Villar MT, Dorko K, Nawabi A, et al. Dynamic arginine methylation of tumor necrosis factor (TNF) receptor-associated factor 6 regulates toll-like receptor signaling. J Biol Chem. 2015;290:22236\u201349.","journal-title":"J Biol Chem"},{"key":"1086_CR26","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.1074\/jbc.M117.800706","volume":"292","author":"WC Tsai","year":"2017","unstructured":"Tsai WC, Reineke LC, Jain A, Jung SY, Lloyd RE. Histone arginine demethylase JMJD6 is linked to stress granule assembly through demethylation of the stress granule-nucleating protein G3BP1. J Biol Chem. 2017;292:18886\u201396.","journal-title":"J Biol Chem"},{"key":"1086_CR27","doi-asserted-by":"publisher","first-page":"9814038","DOI":"10.1155\/2016\/9814038","volume":"2016","author":"S Vrankova","year":"2016","unstructured":"Vrankova S, Barta A, Klimentova J, Dovinova I, Liskova S, Dobesova Z, et al. The regulatory role of nuclear factor kappa B in the heart of hereditary hypertriglyceridemic rat. Oxid Med Cell Longev. 2016;2016:9814038.","journal-title":"Oxid Med Cell Longev"},{"key":"1086_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0092-8674(00)81699-2","volume":"95","author":"T Huxford","year":"1998","unstructured":"Huxford T, Huang DB, Malek S, Ghosh G. The crystal structure of the IkappaBalpha\/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell. 1998;95:759\u201370.","journal-title":"Cell"},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","volume":"95","author":"MD Jacobs","year":"1998","unstructured":"Jacobs MD, Harrison SC. Structure of an IkappaBalpha\/NF-kappaB complex. Cell. 1998;95:749\u201358.","journal-title":"Cell"},{"key":"1086_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cellsig.2010.03.017","volume":"22","author":"B Huang","year":"2010","unstructured":"Huang B, Yang XD, Lamb A, Chen LF. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal. 2010;22:1282\u201390.","journal-title":"Cell Signal"},{"key":"1086_CR31","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1158\/0008-5472.CAN-15-1022","volume":"75","author":"T Lu","year":"2015","unstructured":"Lu T, Stark GR. NF-kappaB: regulation by methylation. Cancer Res. 2015;75:3692\u20135.","journal-title":"Cancer Res"},{"key":"1086_CR32","doi-asserted-by":"publisher","first-page":"18972","DOI":"10.1073\/pnas.0910439106","volume":"106","author":"CK Ea","year":"2009","unstructured":"Ea CK, Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA. 2009;106:18972\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1968","volume":"12","author":"D Levy","year":"2011","unstructured":"Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P, et al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol. 2011;12:29\u201336.","journal-title":"Nat Immunol"},{"key":"1086_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.0912493107","volume":"107","author":"T Lu","year":"2010","unstructured":"Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, et al. Regulation of NF-kappaB by NSD1\/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci USA. 2010;107:46\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/emboj.2009.55","volume":"28","author":"XD Yang","year":"2009","unstructured":"Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J. 2009;28:1055\u201366.","journal-title":"EMBO J"},{"key":"1086_CR36","doi-asserted-by":"publisher","first-page":"13516","DOI":"10.1073\/pnas.1311784110","volume":"110","author":"H Wei","year":"2013","unstructured":"Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-kappaB. Proc Natl Acad Sci USA. 2013;110:13516\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00204-018-2342-5","volume":"93","author":"Y Hu","year":"2019","unstructured":"Hu Y, Guo Z, Lu J, Wang P, Sun S, Zhang Y, et al. sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats. Arch Toxicol. 2019;93:533\u201346.","journal-title":"Arch Toxicol"},{"key":"1086_CR38","doi-asserted-by":"publisher","first-page":"jcs228478","DOI":"10.1242\/jcs.228478","volume":"132","author":"L Liang","year":"2019","unstructured":"Liang L, Tu Y, Lu J, Wang P, Guo Z, Wang Q, et al. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt\/beta-catenin signaling pathway. J Cell Sci. 2019;132:jcs228478.","journal-title":"J Cell Sci"},{"key":"1086_CR39","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1002\/jcb.26649","volume":"120","author":"S Sun","year":"2019","unstructured":"Sun S, Hu Y, Zheng Q, Guo Z, Sun D, Chen S, et al. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity. J Cell Biochem. 2019;120:4813\u201326.","journal-title":"J Cell Biochem"},{"key":"1086_CR40","doi-asserted-by":"publisher","first-page":"548605","DOI":"10.3389\/fcell.2020.548605","volume":"8","author":"P Wang","year":"2020","unstructured":"Wang P, Lan R, Guo Z, Cai S, Wang J, Wang Q, et al. Histone demethylase JMJD3 mediated doxorubicin-induced cardiomyopathy by suppressing SESN2 expression. Front Cell Dev Biol. 2020;8:548605.","journal-title":"Front Cell Dev Biol"},{"key":"1086_CR41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/bph.14538","volume":"176","author":"J Li","year":"2019","unstructured":"Li J, Huang J, Lu J, Guo Z, Li Z, Gao H, et al. Sirtuin 1 represses PKC-zeta activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy. Br J Pharmacol. 2019;176:416\u201335.","journal-title":"Br J Pharmacol"},{"key":"1086_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.apsb.2018.10.008","volume":"9","author":"J Lu","year":"2019","unstructured":"Lu J, Li J, Hu Y, Guo Z, Sun D, Wang P, et al. Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation. Acta Pharm Sin B 2019;9:782\u201393.","journal-title":"Acta Pharm Sin B"},{"key":"1086_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejphar.2015.05.056","volume":"761","author":"Z Guo","year":"2015","unstructured":"Guo Z, Liao Z, Huang L, Liu D, Yin D, He M. Kaempferol protects cardiomyocytes against anoxia\/reoxygenation injury via mitochondrial pathway mediated by SIRT1. Eur J Pharmacol. 2015;761:245\u201353.","journal-title":"Eur J Pharmacol"},{"key":"1086_CR44","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3389\/fphar.2018.01519","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Zhang X, Guo Z, Zhong Y, Wang P, Li J, et al. SIRT6 suppresses NFATc4 expression and activation in cardiomyocyte hypertrophy. Front Pharmacol. 2018;9:1519.","journal-title":"Front Pharmacol"},{"key":"1086_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jacbts.2022.09.010","volume":"8","author":"Z Guo","year":"2023","unstructured":"Guo Z, Valenzuela Ripoll C, Picataggi A, Rawnsley D, Ozcan M, Chirinos J, et al. Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury. JACC Basic Transl Sci. 2023;8:340\u201355.","journal-title":"JACC Basic Transl Sci"},{"key":"1086_CR46","doi-asserted-by":"publisher","unstructured":"Ozcan M, Guo Z, Valenzuela Ripoll C, Diab A, Picataggi A, Rawnsley D, et al. Sustained alternate day fasting potentiates doxorubicin cardiotoxicity. Cell Metab. 2023. Online ahead of print. https:\/\/doi.org\/10.1016\/j.cmet.2023.02.006.","DOI":"10.1016\/j.cmet.2023.02.006"},{"key":"1086_CR47","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2337\/db20-0591","volume":"70","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhang Y, Liu C, Youn JY, Cai H. Toll-like receptor 2 (TLR2) knockout abrogates diabetic and obese phenotypes while restoring endothelial function via inhibition of NOX1. Diabetes. 2021;70:2107\u201319.","journal-title":"Diabetes"},{"key":"1086_CR48","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.18632\/aging.101506","volume":"10","author":"W Luo","year":"2018","unstructured":"Luo W, Wang Y, Yang H, Dai C, Hong H, Li J, et al. Heme oxygenase-1 ameliorates oxidative stress-induced endothelial senescence via regulating endothelial nitric oxide synthase activation and coupling. Aging (Albany NY). 2018;10:1722\u201344.","journal-title":"Aging (Albany NY)"},{"key":"1086_CR49","doi-asserted-by":"publisher","first-page":"W249","DOI":"10.1093\/nar\/gkl233","volume":"34","author":"H Chen","year":"2006","unstructured":"Chen H, Xue Y, Huang N, Yao X, Sun Z. MeMo: a web tool for prediction of protein methylation modifications. Nucleic Acids Res. 2006;34:W249\u2013W253.","journal-title":"Nucleic Acids Res"},{"key":"1086_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCHEARTFAILURE.114.001297","volume":"8","author":"H Javan","year":"2015","unstructured":"Javan H, Szucsik AM, Li L, Schaaf CL, Salama ME, Selzman CH. Cardiomyocyte p65 nuclear factor-kappaB is necessary for compensatory adaptation to pressure overload. Circ Heart Fail. 2015;8:109\u201318.","journal-title":"Circ Heart Fail"},{"key":"1086_CR51","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","volume":"375","author":"S Gupta","year":"2008","unstructured":"Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol. 2008;375:637\u201349.","journal-title":"J Mol Biol"},{"key":"1086_CR52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/aps.2017.58","volume":"39","author":"HQ Hong","year":"2018","unstructured":"Hong HQ, Lu J, Fang XL, Zhang YH, Cai Y, Yuan J, et al. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-kappaB signaling pathway. Acta Pharmacol Sin. 2018;39:184\u201394.","journal-title":"Acta Pharmacol Sin"},{"key":"1086_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1476-5381.2012.01903.x","volume":"168","author":"SS Yu","year":"2013","unstructured":"Yu SS, Cai Y, Ye JT, Pi RB, Chen SR, Liu PQ, et al. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-kappaB-dependent transcriptional activity. Br J Pharmacol. 2013;168:117\u201328.","journal-title":"Br J Pharmacol"},{"key":"1086_CR54","doi-asserted-by":"publisher","first-page":"30353","DOI":"10.1074\/jbc.274.43.30353","volume":"274","author":"H Sakurai","year":"1999","unstructured":"Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem. 1999;274:30353\u20136.","journal-title":"J Biol Chem"},{"key":"1086_CR55","doi-asserted-by":"publisher","first-page":"34538","DOI":"10.1074\/jbc.M504943200","volume":"280","author":"CY Sasaki","year":"2005","unstructured":"Sasaki CY, Barberi TJ, Ghosh P, Longo DL. Phosphorylation of RelA\/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem. 2005;280:34538\u201347.","journal-title":"J Biol Chem"},{"key":"1086_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","volume":"98","author":"J Backs","year":"2006","unstructured":"Backs J, Olson EN. Control of cardiac growth by histone acetylation\/deacetylation. Circ Res. 2006;98:15\u201324.","journal-title":"Circ Res"},{"key":"1086_CR57","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","volume":"10","author":"JY Ooi","year":"2015","unstructured":"Ooi JY, Tuano NK, Rafehi H, Gao XM, Ziemann M, Du XJ, et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Epigenetics. 2015;10:418\u201330.","journal-title":"Epigenetics"},{"key":"1086_CR58","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1073\/pnas.1315155110","volume":"110","author":"R Papait","year":"2013","unstructured":"Papait R, Cattaneo P, Kunderfranco P, Greco C, Carullo P, Guffanti A, et al. Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc Natl Acad Sci USA. 2013;110:20164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR59","doi-asserted-by":"publisher","first-page":"5081323","DOI":"10.1155\/2020\/5081323","volume":"2020","author":"R Zang","year":"2020","unstructured":"Zang R, Tan Q, Zeng F, Wang D, Yu S, Wang Q. JMJD1A represses the development of cardiomyocyte hypertrophy by regulating the expression of catalase. Biomed Res Int. 2020;2020:5081323.","journal-title":"Biomed Res Int"},{"key":"1086_CR60","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fphys.2020.00539","volume":"11","author":"S Yu","year":"2020","unstructured":"Yu S, Li Y, Zhao H, Wang Q, Chen P. The Histone demethylase JMJD1C regulates CAMKK2-AMPK signaling to participate in cardiac hypertrophy. Front Physiol. 2020;11:539.","journal-title":"Front Physiol"},{"key":"1086_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fgene.2018.00014","volume":"9","author":"W Rosales","year":"2018","unstructured":"Rosales W, Lizcano F. The histone demethylase JMJD2A modulates the induction of hypertrophy markers in iPSC-derived cardiomyocytes. Front Genet. 2018;9:14.","journal-title":"Front Genet"},{"key":"1086_CR62","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jchf.2017.09.009","volume":"5","author":"MR Bristow","year":"2017","unstructured":"Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J 3rd, Gill EA, et al. Structural and functional phenotyping of the failing heart: Is the left ventricular ejection fraction obsolete? JACC Heart Fail. 2017;5:772\u201381.","journal-title":"JACC Heart Fail"},{"key":"1086_CR63","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810\u201352.","journal-title":"Circulation."},{"key":"1086_CR64","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA. 2001;98:6668\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1086_CR65","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvp237","volume":"84","author":"L Zelarayan","year":"2009","unstructured":"Zelarayan L, Renger A, Noack C, Zafiriou MP, Gehrke C, van der Nagel R, et al. NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res. 2009;84:416\u201324.","journal-title":"Cardiovasc Res"},{"key":"1086_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mce.2014.03.007","volume":"390","author":"J Zou","year":"2014","unstructured":"Zou J, Li H, Chen X, Zeng S, Ye J, Zhou C, et al. C\/EBPbeta knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFkappaB. Mol Cell Endocrinol. 2014;390:18\u201325.","journal-title":"Mol Cell Endocrinol"},{"key":"1086_CR67","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1074\/jbc.M110572200","volume":"277","author":"N Sizemore","year":"2002","unstructured":"Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem. 2002;277:3863\u20139.","journal-title":"J Biol Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01086-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T11:38:53Z","timestamp":1702294733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01086-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1038\/s41401-023-01086-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}